Figure 2.

Expected incremental cost of ceramide-infused skin barrier versus SoC in deterministic sensitivity analyses. The vertical dotted black line represents incremental per patient cost savings associated with use of ceramide-infused skin barrier in the base case (A$180). Negative estimates indicate expected cost savings associated with use of ceramide-infused skin barrier instead of SoC. acc indicates accessories; add, addition; bp, baseplate; CIB, ceramide-infused skin barrier; inc, increase; pce, piece; pr, probability; ps, pouching supplies; SoC, standard of care; sys, system.